LDLR and acute myeloid leukemia: In order to obtain support for the “classical” LDL receptor being involved in the elevated uptake and degradation of LDL in leukemic cells we incubated isolated mononuclear blood cells from 3 AML patients with a neutralizing antibody to the LDL receptor.